| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Candel Therapeutics Inc. Common Stock (NASDAQ: CADL)
CADL Technical Analysis
5
| As on 9th Jun 2023 CADL STOCK Price closed @ 1.47 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.01 & Strong Sell for SHORT-TERM with Stoploss of 5.78 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CADLSTOCK Price
| Open | 1.80 | Change | Price | % |
| High | 1.80 | 1 Day | -0.12 | -7.55 |
| Low | 1.45 | 1 Week | 0.02 | 1.38 |
| Close | 1.47 | 1 Month | 0.07 | 5.00 |
| Volume | 41400 | 1 Year | -5.84 | -79.89 |
| 52 Week High 8.40 | 52 Week Low 1.24 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CADL Daily Charts |
CADL Intraday Charts |
Whats New @ Bazaartrend |
CADL Free Analysis |
|
|
CADL Important Levels Intraday
| RESISTANCE | 2.14 |
| RESISTANCE | 1.93 |
| RESISTANCE | 1.79 |
| RESISTANCE | 1.66 |
| SUPPORT | 1.28 |
| SUPPORT | 1.15 |
| SUPPORT | 1.01 |
| SUPPORT | 0.80 |
CADL Forecast April 2024
| 4th UP Forecast | 10.33 |
| 3rd UP Forecast | 7.49 |
| 2nd UP Forecast | 5.73 |
| 1st UP Forecast | 3.98 |
| 1st DOWN Forecast | -1.04 |
| 2nd DOWN Forecast | -2.79 |
| 3rd DOWN Forecast | -4.55 |
| 4th DOWN Forecast | -7.39 |
CADL Weekly Forecast
| 4th UP Forecast | 6.56 |
| 3rd UP Forecast | 4.93 |
| 2nd UP Forecast | 3.92 |
| 1st UP Forecast | 2.91 |
| 1st DOWN Forecast | 0.03 |
| 2nd DOWN Forecast | -0.98 |
| 3rd DOWN Forecast | -1.99 |
| 4th DOWN Forecast | -3.62 |
CADL Forecast2024
| 4th UP Forecast | 16.02 |
| 3rd UP Forecast | 11.35 |
| 2nd UP Forecast | 8.47 |
| 1st UP Forecast | 5.58 |
| 1st DOWN Forecast | -2.64 |
| 2nd DOWN Forecast | -5.53 |
| 3rd DOWN Forecast | -8.41 |
| 4th DOWN Forecast | -13.08 |
Candel Therapeutics Inc. Common Stock ( NASDAQ USA Symbol : CADL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CADL Business Profile
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of cancer immunotherapy drugs. The company offers Gene Mediated Cytotoxic Immunotherapy technology-based drugs that are designed to work with radiation, chemotherapy, and surgery to eradicate residual tumor cells that could lead to recurrence or metastases. Its product candidates include CAN-2409, an off-the-shelf adenovirus product candidate, for the treatment of localized, primary prostate cancer and therapy for pancreatic cancer; and CAN-3110, its HSV product candidate, has been engineered for enhanced specificity and tumor cell killing, while minimizing toxicity on healthy tissue and indicated for the treatment of recurrent high-grade glioma. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. The company was founded in 1999 and is based in Needham, Massachusetts. Address: 117 Kendrick St, Needham, MA, United States, 02494
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service